More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$387206065
EPS
0.33
P/E ratio
19.7
Price to sales
0.89
Dividend yield
0.473%
Beta
1.182434
Previous close
$9.11
Today's open
$8.88
Day's range
$8.44 - $9.02
52 week range
$8.44 - $20.36
show more
CEO
Lawrence Bruno
Employees
3300
Headquarters
Houston, TX
Exchange
New York Stock Exchange
Shares outstanding
45823203
Issue type
Common Stock
Energy
Fossil Fuels
CLB Q3 Earnings Miss Estimates on Higher Costs and Disruptions
Core Laboratories' Q3 earnings missed estimates amid rising costs and geopolitical disruptions, despite a revenue beat and stronger international lab activity.
Zacks Investment Research • Nov 3, 2026

Core Laboratories Q3 Earnings Call Highlights
Core Laboratories NYSE: CLB reported higher third-quarter revenue, operating income and earnings per share from the prior quarter, while geopolitical disruptions in the Middle East and Russia-Ukraine continued to constrain parts of its international services business.
MarketBeat • Oct 30, 2026

Core Laboratories Inc. (CLB) Q3 2026 Earnings Call Transcript
Core Laboratories Inc. ( CLB ) Q3 2026 Earnings Call October 29, 2026 8:30 AM EDT Company Participants Lawrence Bruno - Chairman of the Board, CEO, President & COO Gwendolyn Schreffler - Senior Vice President of Corporate Development & Investor Relations Chris Hill - Senior VP & CFO Conference Call Participants Joshua Jayne - Daniel Energy Partners, LLC Presentation Operator Good morning, and welcome to the Core Laboratories Third Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Seeking Alpha • Oct 29, 2026

CORE LAB REPORTS THIRD QUARTER 2026 RESULTS:
REVENUE OF $ 132.1 MILLION, UP 6% SEQUENTIALLY AND DOWN 2% YEAR-OVER-YEAR OPERATING INCOME OF $ 12.1 MILLION; EX-ITEMS, $12.6 MILLION, UP 35% SEQUENTIALLY AND DOWN 24% YEAR-OVER-YEAR GAAP EARNINGS PER SHARE OF $0.12; EPS EX-ITEMS OF $0.16, UP 46% SEQUENTIALLY AND DOWN 27% YEAR-OVER-YEAR FREE CASH FLOW OF $ 1.7 MILLION COMPANY REPURCHASED 87,873 SHARES OF COMMON STOCK, FOR $1.1 MILLION AGGREGATE PURCHASE PRICE COMPANY ANNOUNCES Q 4 2026 QUARTERLY DIVIDEND HOUSTON, Oct. 28, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported third quarter 2026 revenue of $132,100,000. Core's operating income was $12,100,000, with earnings per diluted share ("EPS") of $0.12, all in accordance with U.S. generally accepted accounting principles ("GAAP").
PRNewsWire • Oct 28, 2026

Core Laboratories (CLB) Q3 Earnings Miss Estimates
Core Laboratories (CLB) came out with quarterly earnings of $0.16 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.22 per share a year ago.
Zacks Investment Research • Oct 29, 2026

CORE LABORATORIES ANNOUNCES TIMING OF THIRD QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL
HOUSTON, Oct. 1, 2026 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its third quarter 2026 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m.
PRNewsWire • Oct 1, 2026

CLB Declines 35% in the Past Six Months: How to Play the Stock?
Core Laboratories' 35.1% six-month slide contrasts with stronger Production Enhancement trends and offshore recovery potential amid geopolitical risks.
Zacks Investment Research • Sep 22, 2026

Top 3 Energy Stocks You'll Regret Missing In September
The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.
Benzinga • Sep 17, 2026

3 Oilfield Services Stocks Poised to Gain Despite Industry Challenges
Strict capital discipline by upstream energy companies is acting as a dampener, making the outlook for the Zacks Oil and Gas-Field Services industry gloomy. FTI, OII and CLB are expected to survive the industry woes.
Zacks Investment Research • Sep 1, 2026

Core Laboratories (CLB) Up 18.7% Since Last Earnings Report: Can It Continue?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research • Aug 28, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Core Laboratories Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.